Hospital M&A has hit the brakes

Hospital M&A activity slowed quite a bit in the first half of 2025, with deal volume and transacted revenue falling sharply amid economic uncertainty and sweeping policy changes. While traditional mergers may remain sluggish, analysts expect a rise in outpatient partnerships and rural hospital conversions toward the end of the year.

Editor's Pick

Top Story Hospital M&A Has Hit the Brakes — But Activity Could Pick Up in the Second Half of 2025 Hospital M&A activity slowed quite a bit in the first half of 2025, with deal volume and transacted revenue falling sharply amid economic uncertainty and sweeping policy changes. While traditional mergers may remain sluggish, analysts expect a rise in outpatient partnerships and rural hospital conversions toward the end of the year. Sponsored The Hidden Cost of Payer-Provider Miscommunication (And How to End It) Presented by Veradigm Tangled workflows and disconnected systems are more than just an inconvenience—they put providers under pressure and patient care at risk. Discover how integrated workflow solutions can streamline communication, reduce administrative burden, and empower providers with the right information at the right time. Better engagement starts here. ➡️ Read More MedCity Pivot Podcast: Why Blood Pressure Monitoring Is Due for A New Era - MedCity News CoraVie Medical CEO Aimee Garza and Dr. Michael Bloch, a hypertension specialist and clinical advisor for the startup, talk about why the healthcare industry needs a better approach to blood pressure monitoring. CoraVie is developing an implantable device that measures patients' blood pressure, operating in a similar way to continuous glucose monitors. Watch or listen now!

Featured News

Is Payers' Provider Data "Clean, Complete, and Centralized" or is There a Crisis of Overconfidence? [Sponsored] In this whitepaper, ProviderTrust outlines the overwhelmingly positive survey results and compares them to our experiences getting up close and personal with the provider data in question. AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma AbbVie has acquired rights to a multispecific antibody that IGI Therapeutics designed to bind to three targets to treat multiple myeloma. Early Phase 1 results showed encouraging responses in a heavily pretreated patient population and a favorable safety profile. Rethinking Masculinity in Men's Health Too many men ignore symptoms until they can no longer function. We end up seeing them in the emergency room, sometimes with late-stage cancer or uncontrolled chronic disease that could have been managed if addressed earlier. AI Meets Gene Editing: the Path to Plug-and-Play Drug Development AI is no panacea, but it can have a role in turning artisanal, trial-and-error drug development into a rapid, cost-effective, data-driven process.

Video   Women's Health Isn't Just About Reproductive Issues About 70% of investment in women's health goes towards wellness and reproductive issues — but that's not a holistic view of women's health, noted Amani Bright of Springboard Enterprises. She thinks more understanding of the full scope of women's health will lead to more investment. After all, women make up half of the population, so there is a huge investment opportunity when it comes to women's health outside of the scope of reproductive organs, Bright said.

Sponsored Expert Care in Houston: Top-Rated Hand and Wrist Surgeons You Can Trust Presented by Fondren Orthopedic Group Too many people sacrifice their quality of life by putting off a surgical procedure. Discover the top-rated hand and wrist surgeons in the Houston area who can help. Learn More.

Resources

MedCity FemFwd: Inside Springboard Enterprises and Accenture's New Women's Health Report In this episode, we're joined by Julia Lasater, management consulting senior analyst at Accenture, and Amani Bright, senior program manager at Springboard Enterprises. They discuss the key takeaways of their recent women's health report. Watch now!

MedCity News • PO Box 901 • New York, NY unsubscribe